This post-approval study has not been publically released by the fda. It may be a place-holder supplement number.
Device | P160042S013 |
Classification Name | None |
Applicant | |
PMA | P160042 |
Supplement | S013 |
Supplement Number | Date | Supplement Type |
---|---|---|
P160042 | Original Filing | |
S017 | 2021-10-05 | 135 Review Track For 30-day Notice |
S016 | ||
S015 | 2021-03-17 | Special (immediate Track) |
S014 | ||
S013 | ||
S012 | 2020-07-15 | Real-time Process |
S011 | 2020-01-22 | Real-time Process |
S010 | ||
S009 | 2019-05-06 | 30-day Notice |
S008 | ||
S007 | ||
S006 | ||
S005 | ||
S004 | 2018-05-29 | Normal 180 Day Track |
S003 | 2017-12-20 | Normal 180 Day Track |
S002 | ||
S001 | 2017-08-14 | Normal 180 Day Track No User Fee |
Device ID | PMA | Supp |
---|---|---|
66980800001000 | P160042 | 000 |
66980800001017 | P160042 | 003 |
66980800001024 | P160042 | 004 |
10669808003032 | P160042 | 014 |